{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:46:37Z","timestamp":1793321197220,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0994-9","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T06:51:57Z","timestamp":1544597517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Simultaneous bilateral posterior ischemic optic neuropathy secondary to giant cell arteritis: a case presentation and review of the literature"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8870-3274","authenticated-orcid":false,"given":"Anas Mohammad","family":"Albarrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufia","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taim","family":"Muayqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"10","key":"994_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","volume":"13","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev. Rheumatol. 2017;13(10):578\u201392.","journal-title":"Nat Rev. Rheumatol."},{"issue":"5","key":"994_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00005792-199909000-00002","volume":"78","author":"MA Gonzalez-Gay","year":"1999","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988\u20131997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78(5):292\u2013308.","journal-title":"Clinical and epidemiologic aspects. Medicine (Baltimore)."},{"issue":"9","key":"994_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","volume":"8","author":"C Salvarani","year":"2012","unstructured":"Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev. Rheumatol. 2012;8(9):509\u201321.","journal-title":"Nat Rev. Rheumatol."},{"issue":"4","key":"994_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","volume":"125","author":"SS Hayreh","year":"1998","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509\u201320.","journal-title":"Am J Ophthalmol."},{"issue":"12","key":"994_CR5","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s00417-016-3434-7","volume":"254","author":"E Smit De","year":"2016","unstructured":"De Smit E, O\u2019Sullivan E, Mackey DA, Hewitt AW. Giant cell arteritis: ophthalmic manifestations of a systemic disease. Graefe\u2019s Arch Clin Exp Ophthalmol. 2016;254(12):2291\u2013306 Available from: \n                    https:\/\/doi.org\/10.1007\/s00417-016-3434-7\n                    \n                  .","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"994_CR6","doi-asserted-by":"crossref","unstructured":"Vodopivec I, Rizzo JF. Ophthalmic manifestations of giant cell arteritis. Rheumatol (United Kingdom). 2018;57(May):ii63-ii72.","DOI":"10.1093\/rheumatology\/kex428"},{"issue":"6","key":"994_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/bjo.2006.108845","volume":"91","author":"IA Chaudhry","year":"2007","unstructured":"Chaudhry IA, Shamsi FA, Elzaridi E, Arat YO, Bosley TM, Riley FC. Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol. 2007;91(6):715\u20138.","journal-title":"Br J Ophthalmol."},{"key":"994_CR8","doi-asserted-by":"publisher","unstructured":"Garrity ST, Pistilli M, Vaphiades MS, Richards NQ, Subramanian PS, Rosa PR, et al. Ophthalmic presentation of giant cell arteritis in African-Americans. Eye 2017;31(1):113\u20138. Available from: \n                    https:\/\/doi.org\/10.1038\/eye.2016.199","DOI":"10.1038\/eye.2016.199"},{"issue":"1","key":"994_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13075-017-1479-6","volume":"19","author":"LK Brekke","year":"2017","unstructured":"Brekke LK, Diamantopoulos AP, Fevang B-T, A\u03b2mus J, Esper\u00f8 E, Gjesdal CG. Incidence of giant cell arteritis in Western Norway 1972\u20132012: a retrospective cohort study. Arthritis Res Ther. 2017;19(1):278 Available from: \n                    https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1479-6\n                    \n                  .","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"994_CR10","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454\u201361.","journal-title":"Arthritis Rheum."},{"issue":"5","key":"994_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","volume":"84","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84(5):269\u201376.","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"994_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","volume":"111","author":"E Liozon","year":"2001","unstructured":"Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001;111(3):211\u20137.","journal-title":"Am J Med."},{"issue":"2","key":"994_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3899\/jrheum.140188","volume":"42","author":"AG Singh","year":"2015","unstructured":"Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol. 2015;42(2):309\u201315.","journal-title":"J Rheumatol."},{"issue":"4","key":"994_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0889-857X(05)70235-0","volume":"27","author":"NR Miller","year":"2001","unstructured":"Miller NR. Visual manifestations of temporal arteritis. Rheum Dis Clin North Am. 2001;27(4):781\u201397 vi.","journal-title":"Rheum Dis Clin North Am."},{"issue":"5","key":"994_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0002-9394(01)01199-0","volume":"132","author":"SR Sadda","year":"2001","unstructured":"Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132(5):743\u201350.","journal-title":"Am J Ophthalmol."},{"issue":"25","key":"994_CR16","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1056\/NEJMra1413352","volume":"372","author":"V Biousse","year":"2015","unstructured":"Biousse V, Newman NJ. Ischemic Optic Neuropathies. N Engl J Med [Internet]. 2015;372(25):2428\u201336 Available from: \n                    http:\/\/www.nejm.org\/doi\/10.1056\/NEJMra1413352\n                    \n                  .","journal-title":"N Engl J Med [Internet]."},{"issue":"11","key":"994_CR17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/sj.eye.6701562","volume":"18","author":"SS Hayreh","year":"2004","unstructured":"Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis. and management. Eye (Lond). 2004;18(11):1188\u2013206.","journal-title":"and management. Eye (Lond)."},{"issue":"4","key":"994_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00041327-199912000-00005","volume":"19","author":"AG Lee","year":"1999","unstructured":"Lee AG, Eggenberger ER, Kaufman DI, Manrique C. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuroophthalmol. 1999;19(4):235\u20137.","journal-title":"J Neuroophthalmol."},{"issue":"5\u20136","key":"994_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/08820538.2010.518450","volume":"25","author":"M He","year":"2010","unstructured":"He M, Cestari D, Cunnane MB, Rizzo JF. The use of diffusion MRI in ischemic optic neuropathy and optic neuritis. Semin Ophthalmol. 2010;25(5\u20136):225\u201332.","journal-title":"Semin Ophthalmol."},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4236\/ojoph.2013.33013","volume":"3","author":"NP Bhatt","year":"2013","unstructured":"Bhatt NP, Morales RE. Mathews MK. MRI findings in Post-operative Bilateral Posterior Ischemic Optic Neuropathy. Open J Ophthalmol. 2013;3:51\u20133.","journal-title":"Open J Ophthalmol."},{"issue":"6","key":"994_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","volume":"112","author":"H Danesh-Meyer","year":"2005","unstructured":"Danesh-Meyer H, Savino PJ, Gamble GG. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology. 2005;112(6):1098\u2013103.","journal-title":"Ophthalmology."},{"issue":"11","key":"994_CR22","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","volume":"101","author":"GT Liu","year":"1994","unstructured":"Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101(11):1779\u201385.","journal-title":"Ophthalmology."},{"key":"994_CR23","doi-asserted-by":"publisher","unstructured":"Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual Prognosis in Giant Cell Arteritis. Ophthalmology [Internet]. 1993;100(4):550\u2013555. Available from: \n                    https:\/\/doi.org\/10.1016\/S0161-6420\n                    \n                  (93)31608-8.","DOI":"10.1016\/S0161-6420"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0994-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-018-0994-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0994-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T19:15:37Z","timestamp":1576091737000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0994-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0994-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"317"}}